Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetic Interaction Trial of Clofutriben With Midazolam and Prednisolone
NCT07226635Phase 1Completed
- Sponsor
- Sparrow Pharmaceuticals
- Start
- Oct 2025
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of clofutriben in Cushing's syndrome, sponsored by Sparrow Pharmaceuticals. Primary endpoints: Maximum Plasma Concentration at 24 hours and Area Under the Curve from Time Zero to Last Quantifiable Concentration at 24 hours. Started Oct 2025; status: completed.
02
Drugs
clofutriben
03
Conditions
Cushing's syndrome
Beyond the preview
Go deeper on NCT07226635.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07226635.